Dates:

Monday, November 11th, 2024 from 9:00am - 5:20pm ET

Tuesday, November 12th, 2024 from 9:00am - 5:20pm ET

Wednesday, November 13th, 2024 from 9:00am - 5:20pm ET

Registration: $800 per person, or $600 for groups discounts of 5 people or more.

Virtual Course Description:

CFSRE presents a reprise of its 2018 NPS Symposium on November 11-13, 2024, in Philadelphia, PA. This event focusing on Novel Synthetic Drug Threats will be held as a HYBRID Symposium at the Science History Institute in Downtown Philadelphia, and available in real time and later, on-demand to those who attend the Symposium. The goal is to bring together international thought leaders and scientists, policy makers, health professionals, public health and public safety stakeholders working in or impacted by Novel Synthetic Drugs Crisis. The program will have a focus on global impacts of NPS. Professionals from across the world will share current knowledge on NPS trends and emerging threats, review of tools and workflows that have developed over recent years and will work together to imagine and anticipate some of the challenges in NPS in the years ahead.

Over the course of the three days, ten panels of invited international experts representing the latest work on novel synthetic drug pharmacology, detection and identification, harm reduction initiatives based on analytical drug checking data, and many other topics. Participants who are able to travel are encouraged to attend in person, to take full advantage of the interactive discussion sessions built into the program and the social/interaction opportunities of the event.

The goal of the symposium is to encourage information exchange, improve international cooperation and communication on the increasingly important topic of new and emerging drugs, and to share new discoveries, best practices, and insights not what is coming next in the world of new and emerging drug threats.

We are proud to announce confirmed speakers and introduce generalized format and topic areas. As we await final confirmation from our additional invited experts, be mindful of the fact that the Science History Institute has limited seating capacity so early registration is highly recommended. We are working to finalize the program but the general format and topic areas for the event can be seen below:

Sessions:

• Panel 1: International Trends – Main Threats
• Panel 2: Emerging Threats and the Future of NPS
• Panel 3: NPS Trafficking & Surveillance
• Panel 4: NPS Identification Challenges and Resources
• Panel 5: NPS Pharmacological Threat Assessment
• Panel 6: NPS Outbreak Event Testing
• Panel 7: Synthetic Drugs Policy and Legislation
• Panel 8: Public Health Drug Checking Programs and Harm Reduction
• Panel 9: NPS Clinical Intoxication Case Round Table
• Panel 10: NPS Postmortem Intoxication Case Round Table

Confirmed Presenters Include:

• Members of the CFSRE’s NPS Discovery® Team:
  • Barry Logan PhD, Alex Krotulski PhD, Joshua DeBord PhD, Mandi Mohr, Sara Walton
• Expert Community on Early Warning and Surveillance Systems, Toxicology, Pharmacology, Pathology, and Clinical Medicine:
  • Richard Bade PhD, University of Queensland, Australia
  • Michael Baumann PhD, NIDA Designer Drug Research Unit, Baltimore USA
  • Thom Browne, Colombo Plan, Colombo, Sri Lanka
  • Larry (Dave) Fluty, Assistant Commissioner US Customs and Border Protection, Laboratories and Scientific Services Division, Washington DC
  • Donna Iula PhD, Cayman Chemical, Ann Arbor MI, USA
  • Wendy Lee, Illicit Drugs Laboratory, HSA, Singapore
  • Karen Macdonald, Toronto Drug Checking Service, St Michaels Hospital, Toronto, Canada
  • Dr Alex Manini, Director of the Mount Sinai Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND Center)
  • Robert Middleberg PhD, Laboratory Director, NMS Labs
  • Dr Lewis Nelson, Professor and Chair Department of Emergency Medicine at Rutgers New Jersey Medical School, NJ USA;
  • Donna Papsun, NMS Labs Horsham PA
  • Jennifer Schumann PhD, EDNA, Monash University, Melbourne, Australia
  • Istvan Ujvary PhD, Honorary Associate Professor at Budapest University of Technology & Economics, Budapest, Hungary
  • Representatives of the newly created European Union Drugs Agency (EUDA, formerly EMCDDA)

Detailed Learning Objectives:

After attending this program, participants will:

• Be able to discuss the latest trends in new and emerging drug threats;
• Be able to identify opportunities for interdisciplinary collaboration of generating and using novel synthetic drug data to improve public health and safety outcomes;
• Have developed and extended their individual professional networks to be more effective in understanding and counteracting the threats of new and emerging synthetic drugs.

*At the CFSRE, we always record all of our LIVE events and convert them into an archival, on-demand recording. This allows our attendees to view the event at a time that is more convenient for their schedules, as well as revisit the material at anytime for a refresher of the course. We typically have the archival recordings back into the system for viewing within 24 hours of completion of that day’s event. For the NPS Symposium we will have the recordings labeled in the specific days folder before the next day’s presentations begin! This quick turnaround for our recordings will help keep the attendees viewing the archivals as close to real time as possible during the course of the week’s presentations.

Click the Enroll button below to register for the NPS Discovery: 2024 Novel Synthetic Drugs Threat Symposium - Virtual Symposium!